用于预防和控制呼吸道过敏和感染的鼻内过滤器。多方利益相关者评估。

Q3 Medicine
Marta Rigoni, Valeria Cento, Carlo Federico Perno, Martina Barchitta, Antonella Agodi, Sergio Bonini, Fabiana Furci, Silvana D'Alessio, Simona Barbaglia, Sandra Frateiacci, Annarosa Racca, Giuseppe Fornasa, Francesco Broccolo, Guido Rasi, Giuseppe Recchia, Lucio Da Ros, Giandomenico Nollo
{"title":"用于预防和控制呼吸道过敏和感染的鼻内过滤器。多方利益相关者评估。","authors":"Marta Rigoni, Valeria Cento, Carlo Federico Perno, Martina Barchitta, Antonella Agodi, Sergio Bonini, Fabiana Furci, Silvana D'Alessio, Simona Barbaglia, Sandra Frateiacci, Annarosa Racca, Giuseppe Fornasa, Francesco Broccolo, Guido Rasi, Giuseppe Recchia, Lucio Da Ros, Giandomenico Nollo","doi":"10.1701/4518.45174","DOIUrl":null,"url":null,"abstract":"<p><p>Healthcare innovations aim to develop and provide technologies, services, and health policies to improve population health and well-being at a global level. Among innovative medical devices (MD), endonasal filters (EF) are designed to improve breathing and capture fine dust and allergens in the surrounding environment acting as a mechanical barrier to the passage of allergens, pathogenic microorganisms and dust. This paper aimed to: i) review the features of EF commercially available, regulatory classification, and their potential role in public health as useful innovative devices; ii) review their role in prevention and control of respiratory infections; iii) review their role in prevention and control of allergic respiratory diseases. A review of MD on the market was carried out through official Ministry of Health, commercial and pharmaceutical channels. Moreover, three separate literature reviews were done by the involved multidisciplinary team. The analysis of the European market, with particular attention to Italy, on available MD identified seven brands of EF. A search conducted at 16th April 2023 in Italian MD Database of the Ministry of Health revealed that three products were registered as MD and they were available on the Italian market. Literature review found 3 studies on nasal filter technical description, 4 studies on patients on infectious diseases and other applications, and 13 studies on patients on respiratory allergy. Studies on infectious diseases were one review, and one correspondence reporting a research proposal. Studies on respiratory allergy included 3 randomized controlled studies, 5 observational open-label non-randomized studies, 2 case series, 1 case report, 1 review, and 1 systematic review. Despite reasonable theoretical fundamentals to claim that EF might contribute to the reduction of infection viral load, current evidence supporting the use of such filters is still scarce, suggesting the need to further research and comprehensive assessments for developing ad hoc documents, guidelines and recommendations.</p>","PeriodicalId":20887,"journal":{"name":"Recenti progressi in medicina","volume":"116 6","pages":"357-370"},"PeriodicalIF":0.0000,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Endonasal filters for the prevention and control of respiratory allergy and infections. A multi-stakeholder assessment.\",\"authors\":\"Marta Rigoni, Valeria Cento, Carlo Federico Perno, Martina Barchitta, Antonella Agodi, Sergio Bonini, Fabiana Furci, Silvana D'Alessio, Simona Barbaglia, Sandra Frateiacci, Annarosa Racca, Giuseppe Fornasa, Francesco Broccolo, Guido Rasi, Giuseppe Recchia, Lucio Da Ros, Giandomenico Nollo\",\"doi\":\"10.1701/4518.45174\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Healthcare innovations aim to develop and provide technologies, services, and health policies to improve population health and well-being at a global level. Among innovative medical devices (MD), endonasal filters (EF) are designed to improve breathing and capture fine dust and allergens in the surrounding environment acting as a mechanical barrier to the passage of allergens, pathogenic microorganisms and dust. This paper aimed to: i) review the features of EF commercially available, regulatory classification, and their potential role in public health as useful innovative devices; ii) review their role in prevention and control of respiratory infections; iii) review their role in prevention and control of allergic respiratory diseases. A review of MD on the market was carried out through official Ministry of Health, commercial and pharmaceutical channels. Moreover, three separate literature reviews were done by the involved multidisciplinary team. The analysis of the European market, with particular attention to Italy, on available MD identified seven brands of EF. A search conducted at 16th April 2023 in Italian MD Database of the Ministry of Health revealed that three products were registered as MD and they were available on the Italian market. Literature review found 3 studies on nasal filter technical description, 4 studies on patients on infectious diseases and other applications, and 13 studies on patients on respiratory allergy. Studies on infectious diseases were one review, and one correspondence reporting a research proposal. Studies on respiratory allergy included 3 randomized controlled studies, 5 observational open-label non-randomized studies, 2 case series, 1 case report, 1 review, and 1 systematic review. Despite reasonable theoretical fundamentals to claim that EF might contribute to the reduction of infection viral load, current evidence supporting the use of such filters is still scarce, suggesting the need to further research and comprehensive assessments for developing ad hoc documents, guidelines and recommendations.</p>\",\"PeriodicalId\":20887,\"journal\":{\"name\":\"Recenti progressi in medicina\",\"volume\":\"116 6\",\"pages\":\"357-370\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Recenti progressi in medicina\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1701/4518.45174\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Recenti progressi in medicina","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1701/4518.45174","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

摘要

医疗保健创新旨在开发和提供技术、服务和卫生政策,以改善全球人口的健康和福祉。在创新医疗设备(MD)中,鼻内过滤器(EF)旨在改善呼吸并捕获周围环境中的细粉尘和过敏原,作为过敏原,病原微生物和粉尘通过的机械屏障。本文的目的是:i)回顾了可商用的EF的特点、监管分类以及它们作为有用的创新器械在公共卫生中的潜在作用;Ii)审查它们在预防和控制呼吸道感染方面的作用;Iii)综述它们在预防和控制过敏性呼吸道疾病中的作用。通过卫生部的官方渠道、商业和制药渠道对市场上的MD进行了审查。此外,三个独立的文献综述是由相关的多学科团队完成的。对欧洲市场的分析,特别关注意大利,在现有的MD上确定了七个品牌的EF。2023年4月16日在卫生部的意大利MD数据库中进行的搜索显示,三种产品已注册为MD,并可在意大利市场上购买。文献查阅发现3篇关于鼻滤器技术描述的研究,4篇关于传染病及其他应用患者的研究,13篇关于呼吸道过敏患者的研究。关于传染病的研究是一篇综述,一篇通信报告一项研究计划。呼吸道过敏的研究包括3项随机对照研究、5项观察性开放标签非随机研究、2项病例系列研究、1项病例报告、1项综述和1项系统综述。尽管合理的理论基础表明,EF可能有助于减少感染病毒载量,但目前支持使用这种过滤器的证据仍然很少,这表明需要进一步研究和全面评估,以制定专门的文件、指南和建议。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Endonasal filters for the prevention and control of respiratory allergy and infections. A multi-stakeholder assessment.

Healthcare innovations aim to develop and provide technologies, services, and health policies to improve population health and well-being at a global level. Among innovative medical devices (MD), endonasal filters (EF) are designed to improve breathing and capture fine dust and allergens in the surrounding environment acting as a mechanical barrier to the passage of allergens, pathogenic microorganisms and dust. This paper aimed to: i) review the features of EF commercially available, regulatory classification, and their potential role in public health as useful innovative devices; ii) review their role in prevention and control of respiratory infections; iii) review their role in prevention and control of allergic respiratory diseases. A review of MD on the market was carried out through official Ministry of Health, commercial and pharmaceutical channels. Moreover, three separate literature reviews were done by the involved multidisciplinary team. The analysis of the European market, with particular attention to Italy, on available MD identified seven brands of EF. A search conducted at 16th April 2023 in Italian MD Database of the Ministry of Health revealed that three products were registered as MD and they were available on the Italian market. Literature review found 3 studies on nasal filter technical description, 4 studies on patients on infectious diseases and other applications, and 13 studies on patients on respiratory allergy. Studies on infectious diseases were one review, and one correspondence reporting a research proposal. Studies on respiratory allergy included 3 randomized controlled studies, 5 observational open-label non-randomized studies, 2 case series, 1 case report, 1 review, and 1 systematic review. Despite reasonable theoretical fundamentals to claim that EF might contribute to the reduction of infection viral load, current evidence supporting the use of such filters is still scarce, suggesting the need to further research and comprehensive assessments for developing ad hoc documents, guidelines and recommendations.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Recenti progressi in medicina
Recenti progressi in medicina Medicine-Medicine (all)
CiteScore
0.90
自引率
0.00%
发文量
143
期刊介绍: Giunta ormai al sessantesimo anno, Recenti Progressi in Medicina continua a costituire un sicuro punto di riferimento ed uno strumento di lavoro fondamentale per l"ampliamento dell"orizzonte culturale del medico italiano. Recenti Progressi in Medicina è una rivista di medicina interna. Ciò significa il recupero di un"ottica globale e integrata, idonea ad evitare sia i particolarismi della informazione specialistica sia la frammentazione di quella generalista.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信